Related Experiment Videos

Matrix metalloproteinase gene polymorphisms: lack of association with chronic obstructive pulmonary disease in a

H Schirmer1, L Basso da Silva, P J Z Teixeira

  • 1Programa de Pós-Graduação em Diagnóstico Genético e Molecular, Universidade Luterana do Brasil, Canoas, RS, Brasil.

Genetics and Molecular Research : GMR
|September 5, 2009
PubMed

Insights

Genetic variations in matrix metalloproteinase (MMP) genes do not appear to increase the risk of developing chronic obstructive pulmonary disease (COPD). This study found no significant association between MMP gene polymorphisms and COPD susceptibility in a Brazilian population sample.

Area of Science:

  • Genetics
  • Pulmonology
  • Biochemistry

Background:

  • Chronic obstructive pulmonary disease (COPD) is a complex respiratory condition with numerous candidate genes implicated in its pathogenesis.
  • Matrix metalloproteinases (MMPs) are enzymes crucial for tissue remodeling and repair, processes dysregulated in COPD.
  • Polymorphisms within MMP genes are hypothesized to influence individual susceptibility to COPD.

Purpose of the Study:

  • To investigate the association between functional polymorphisms in MMP-3, MMP-9, and MMP-12 genes and the risk of developing COPD.
  • To determine if specific genotypes or alleles of these MMP genes are more prevalent in COPD patients compared to healthy controls.

Main Methods:

  • Genotyping of functional polymorphisms (-1171 5A/6A in MMP-3, -1562 C/T in MMP-9, and -82 A/G in MMP-12) using polymerase chain reaction and restriction digestion.
  • Analysis of allele and genotype frequencies in 111 COPD patients and 101 control subjects from a Brazilian sample.
  • Haplotype analysis was performed to assess combinations of polymorphisms.

Main Results:

  • No statistically significant differences were found in the allele frequencies of MMP-3, MMP-9, and MMP-12 polymorphisms between COPD patients and controls.
  • Genotype frequency distributions for the studied MMP polymorphisms did not differ between the patient and control groups.
  • Haplotype analysis revealed no significant association between MMP gene variations and COPD risk.

Conclusions:

  • The examined functional polymorphisms in MMP-3, MMP-9, and MMP-12 genes do not appear to significantly impact the risk of developing COPD.
  • These specific MMP gene variations are unlikely to be major genetic determinants of COPD susceptibility in the studied Brazilian population.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...